Prognostic effect interactions were not significantly different between HER2 status and certain subgroups including age, menstrual status, tumor size, ALN status, tumor grade, ER level, PR level, and Ki-67 level (Supplementary Fig. S1). This evidence concerns the gene ESR1 and neoplasm.